Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of desi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Khan, Jameel Ahmad, Kudgus, Rachel A., Szabolcs, Annamaria, Dutta, Shamit, Wang, Enfeng, Cao, Sheng, Curran, Geoffry L., Shah, Vijay, Curley, Steven, Mukhopadhyay, Debabrata, Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124468/
https://ncbi.nlm.nih.gov/pubmed/21738572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0020347
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires